Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is increasing access to the innovations of its walk-in pharmacy diagnostic technology. Recently, the company expanded from key cities in Canada’s eastern locales to sites on the western seaboard, where it hopes to diversify the profile of patients using its service. “The addition of five British Columbia outlets through Avricore’s pilot partnership with nationwide pharmaceutical chain Shoppers Drug Mart is expected to serve as an early booster stage for the company’s plans to serve 600 locations by the end of 2023,” reads a recent article. In an earlier news release, CEO Hector Bremner commented: “We’ve demonstrated a unique resilience by remaining focused on our goal of creating the world’s largest rapid testing network in a pharmacy… We are well on our way to making actionable health information more accessible for everyone and dramatically expanding our network in the coming months.” Notably, Avricore’s HealthTab(TM) technology, which was recently expanded to provide lab-quality results for prediabetes, also “has the flexibility to work with an array of new partners to detect additional medical conditions from additional populations as time progresses, utilizing the professional skills of neighborhood pharmacists to oversee the process and sharing the data.”
To view the full article, visit https://ibn.fm/6iGXy
About Avricore Health Inc.
Avricore Health is a pharmacy service innovator focused on acquiring and developing early stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab(TM), (a wholly owned subsidiary), its mission is to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies. For more information about the company, visit www.AvricoreHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.